How Are Healthcare AI Developers Responding to WHO's New Guidance on LLMs?
Briefly

"People often have a tendency to 'overstate and overestimate' the capabilities of AI...This can lead to the use of 'unproven products' that haven't been subjected to rigorous evaluation for safety and efficacy, the organization added."
"AI developers should give healthcare stakeholders opportunities to voice concerns and provide input. Developers should also be able to predict and understand any possible secondary outcomes."
Read at MedCity News
[
add
]
[
|
|
]